FDA Staff Takes No Position on Moderna Covid-19 Booster

The staff reviewing the drugmaker’s application for booster authorization didn’t take a stance, a move that appears driven by insufficient data.

Tax Proposals Hit Headwinds as Democrats Try to Finalize Deal

A push by Democrats to fund their social-spending and climate bill...

Big Retailers Becoming Big Property Owners With Warehouse Deals

Companies look to save long-term costs while making a bet on...

Eli Lilly Asks FDA to Approve Alzheimer’s Drug

The drugmaker has begun the process seeking approval to sell donanemab...

U.S. Consumer Confidence Rose as Delta Covid-19 Wave Eased

People plan to spend on big-ticket items and go on vacation...